Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma colistin trough level as a predictor for early colistin nephrotoxicity
TCTR20161227001Recruiting
- Sponsor
- Chulalongkorn University
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of colistimethate sodium in Gram-negative bacterial infection, sponsored by Chulalongkorn University. Primary endpoints: Early colistin-associated nephrotoxicity and Plasma colistin trough concentration. Started May 2016; status: recruiting.
02
Drugs
colistimethate sodium
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on TCTR20161227001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161227001.